Atrial fibrillation
Atrial fibrillation (AF) is one of the most common arrhythmias. It is caused by many small reentry loops caused by the dominant reentry loop of the atrium. The overall incidence of AF is 0.4%. The incidence of AF increases with age and can reach 10% in people over 75 years old. During AF, the frequency of atrial excitation reaches 300-600 beats/min. The heart rate is often fast and irregular, sometimes reaching 100-160 beats/min. It is not only much faster than the heart rate of a normal person, but also absolutely irregular, and the atrium loses its effective contraction function. A large-scale survey in my country shows that the prevalence of AF is 0.77%. The prevalence of AF in men (0.9%) is higher than that in women (0.7%). The prevalence of AF in people over 80 years old is 7.5%. In addition, the increase in the prevalence of AF is closely related to the increase in diseases such as coronary heart disease, hypertension and heart failure. In the next 50 years, AF will become one of the most popular cardiovascular diseases.
-
Site of disease:
heart -
Infectious :
Not contagious -
Frequent population:
Elderly -
Related symptoms:
Chest tightness brain hypoxia fatigue palpitations rapid heartbeat -
Concurrent disease:
Related Drugs
Amiodarone Hydrochloride Tablets
Indication: Oral administration is suitable for the prevention of life-threatening paroxysmal ventricular tachycardia and ventricular fibrillation. It can also be used for paroxysmal supraventricular tachycardia, paroxysmal atrial flutter, and atrial fibrillation that are ineffective with other drugs, including those with preexcitation syndrome and maintenance treatment after electrical cardioversion of persistent atrial fibrillation and atrial flutter. It can be used to control the ventricular rate during persistent atrial fibrillation and atrial flutter. It is generally not suitable for the treatment of atrial and ventricular premature beats unless there are clear indications.
Amiodarone Hydrochloride Tablets
Indication: Oral administration is suitable for the prevention of life-threatening paroxysmal ventricular tachycardia and ventricular fibrillation. It can also be used for paroxysmal supraventricular tachycardia, paroxysmal atrial flutter, and atrial fibrillation that are ineffective with other drugs, including those with preexcitation syndrome and maintenance treatment after electrical cardioversion of persistent atrial fibrillation and atrial flutter. It can be used to control the ventricular rate during persistent atrial fibrillation and atrial flutter. It is generally not suitable for the treatment of atrial and ventricular premature beats unless there are clear indications.
Manufacturer:
Wuhan Wujing Pharmaceutical Co., Ltd.
Amiodarone Hydrochloride Tablets
Indication: Oral administration is suitable for the prevention of life-threatening paroxysmal ventricular tachycardia and ventricular fibrillation. It can also be used for paroxysmal supraventricular tachycardia, paroxysmal atrial flutter, and atrial fibrillation that are ineffective with other drugs, including those with preexcitation syndrome and maintenance treatment after electrical cardioversion of persistent atrial fibrillation and atrial flutter. It can be used to control the ventricular rate during persistent atrial fibrillation and atrial flutter. It is generally not suitable for the treatment of atrial and ventricular premature beats unless there are clear indications.
Manufacturer:
Hainan Pharmaceutical Factory Co., Ltd. Pharmaceutical Factory No.1
Amiodarone Hydrochloride Tablets
Indication: Oral administration is suitable for the prevention of life-threatening paroxysmal ventricular tachycardia and ventricular fibrillation. It can also be used for paroxysmal supraventricular tachycardia, paroxysmal atrial flutter, and atrial fibrillation that are ineffective with other drugs, including those with preexcitation syndrome and maintenance treatment after electrical cardioversion of persistent atrial fibrillation and atrial flutter. It can be used to control the ventricular rate during persistent atrial fibrillation and atrial flutter. It is generally not suitable for the treatment of atrial and ventricular premature beats unless there are clear indications.
Manufacturer:
Shandong XinYi Pharmaceutical Co., Ltd.
Aspirin Enteric-coated Capsules
Indication: This product can inhibit platelet aggregation and prevent thrombosis. It can be used to prevent thrombosis after transient ischemic attack, myocardial infarction, atrial fibrillation, artificial heart valve, arteriovenous fistula or other surgeries. It can also be used to treat unstable angina.
Manufacturer:
Jiangsu GENERAL Pharmaceutical Co., Ltd.
Aspirin Enteric-coated Capsules
Indication: This product can inhibit platelet aggregation and prevent thrombosis. It can be used to prevent thrombosis after transient ischemic attack, myocardial infarction, atrial fibrillation, artificial heart valve, arteriovenous fistula or other surgeries. It can also be used to treat unstable angina.
Manufacturer:
Chongqing Dikang Changjiang Pharmaceutical Co., Ltd.
Aspirin Enteric-coated Capsules
Indication: This product can inhibit platelet aggregation and prevent thrombosis. It can be used to prevent thrombosis after transient ischemic attack, myocardial infarction, atrial fibrillation, artificial heart valve, arteriovenous fistula or other surgeries. It can also be used to treat unstable angina.
Aspirin Enteric-coated Capsules
Indication: This product can inhibit platelet aggregation and prevent thrombosis. It can be used to prevent thrombosis after transient ischemic attack, myocardial infarction, atrial fibrillation, artificial heart valve, arteriovenous fistula or other surgeries. It can also be used to treat unstable angina.
Manufacturer:
Beijing Shuguang Pharm Co., Ltd.
Aspirin Enteric-coated Capsules
Indication: This product can inhibit platelet aggregation and prevent thrombosis. It can be used to prevent thrombosis after transient ischemic attack, myocardial infarction, atrial fibrillation, artificial heart valve, arteriovenous fistula or other surgeries. It can also be used to treat unstable angina.
Manufacturer:
HUAZHONG Pharmaceutical Co., Ltd.
Digoxin
Indication: 1. Used for acute and chronic heart failure such as hypertension, valvular heart disease, congenital heart disease, etc. It is especially suitable for heart failure with atrial fibrillation accompanied by rapid ventricular rate; it has poor efficacy for heart failure caused by cor pulmonale, severe myocardial ischemia, active myocarditis and extracardiac factors such as severe anemia, hypothyroidism and vitamin B1 deficiency; 2. Used to control the ventricular rate and supraventricular tachycardia of patients with atrial fibrillation and atrial flutter accompanied by rapid ventricular rate.
Related Ingredients